PharMerica Reports Third Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Acquisitions, Specialty and Brand Inflation Drive Pharmerica's (PMC) 3Q Beat; Cowen Reiterates Outperform
November 6, 2015 1:45 PM ESTCowen reiterated an Outperform rating and $39.00 price target on PharMerica (NYSE: PMC) following the company's 3Q earnings report. PMC reported 3Q adj. EPS of $0.39, ahead of consensus of $0.36. Revenue of $498.8M was up 6% y/y and also beat consensus of $480.3M, driven by recent... More
Pharmerica (PMC) Tops Q3 EPS by 3c
November 6, 2015 9:17 AM ESTPharmerica (NYSE: PMC) reported Q3 EPS of $0.39, $0.03 better than the analyst estimate of $0.36. Revenue for the quarter came in at $498.8 million versus the consensus estimate of $480.35 million.
For earnings history and earnings-related data on Pharmerica (PMC) click here.
... More